Allergan Settles Suit with InnoPharma Over Restasis

By Staff
Monday, October 16, 2017 12:18 AM DUBLIN—Allergan (NYSE: AGN) and its subsidiaries announced Thursday that the company has reached an agreement with InnoPharma Inc. resolving patent litigation regarding U.S. patents covering its Restasis dry eye drug, which are Orange book-listed and will expire on August 27, 2024.

Optical Industry Gears Up to Celebrate World Sight Day on Oct. 12

By Staff
Wednesday, October 11, 2017 12:36 AM DENVER—Tomorrow Oct. 12 is World Sight Day, when leading North American optometric companies, networks, schools and practices will once again join a coalition led by Optometry Giving Sight in support of World Sight Day and the World Sight Day Challenge, which runs through October, according to an announcement from Optometry Giving Sight.

California Bill, Supported by CAO, Expands Optometrists’ Role

By Staff
Wednesday, October 11, 2017 12:33 AM SACRAMENTO, Calif.—California Governor Jerry Brown  signed legislation that proponents say will expand the practice of optometry in the state.

ASCRS Foundation Sponsors Second Annual National Sight Week

By Staff
Monday, October 9, 2017 12:18 AM FAIRFAX, Va.—The American Society of Cataract and Refractive Surgery (ASCRS) Foundation announced it will be sponsoring the second annual National Sight Week taking place Oct. 15 to 21.

House’s Oversight Committee Set to Investigate Allergan Patent Transfer to Native American Tribe

By Staff
Friday, October 6, 2017 12:27 AM DUBLIN—The move by Allergan plc (NYSE: AGN) to transfer patents for the dry eye treatment Restasis to New York’s Saint Regis Mohawk Tribe is going to be investigated by the House’s Committee on Oversight and Government Reform.

Shire Hits Allergan With a Lawsuit in U.S. District Court Over Marketing of Dry Eye Drugs

By Staff
Wednesday, October 4, 2017 12:27 AM DUBLIN—Two major pharma companies—Allergan plc and Shire plc—are now involved in a lawsuit related to the marketing of their drugs, Restasis and Xiidra.

Lighthouse Guild Moves to New Home and Unveils New Logo

By Staff
Wednesday, October 4, 2017 12:18 AM NEW YORK—Lighthouse Guild celebrated its move to a new location and unveiled a new logo at a ribbon-cutting ceremony on Sept. 28.

Research Demonstrates Full Reversal of Myopia in Animal Model

By Staff
Friday, September 29, 2017 12:21 AM ALPHARETTA, Ga.—The lens design used for NaturalVue Multifocal 1 Day Contact Lenses has been shown to fully reverse previously induced myopia in an animal model (chickens), according to research published in the September edition of Ophthalmic and Physiological Optics.

Professional Eyecare Resource Co-Op and Infinity Vision Alliance Announce illuma Care Partnership

By Staff
Wednesday, September 27, 2017 12:24 AM ATLANTA—Professional Eyecare Resource Co-Operative (PERC) and Infinity Vision Alliance (IVA) have entered into a partnership with illuma Care Connections, a care coordination company offering services to payers and ECPs, that is designed to help solve the care gap experienced by many diabetic patients, the companies announced Tuesday.

Ampleye Scleral Now FDA Approved for Ocular Surface & Dry Eye Disease Management

By Staff
Monday, September 25, 2017 12:30 AM GRAND RAPIDS, Mich.—Art Optical Contact Lens, a leading independent custom lens manufacturer, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on their Ampleye scleral lens for the therapeutic management of ocular surface disease from dry eye.

MacuHealth and M&S Technologies Partner to Advance Patient Care and Treatment Protocols

By Staff
Friday, September 15, 2017 12:15 AM NILES, Ill. and BIRMINGHAM, Mich.—M&S Technologies and MacuHealth, LP have entered into a cooperative marketing agreement. The two companies issued a statement saying they will educate and train eyecare professionals on the direct relationship between enriching macular pigment with nutritional supplements and optimizing visual performance.

Johnson & Johnson Vision Completes Acquisition of Device Manufacturer TearScience

By Staff
Friday, September 8, 2017 12:15 AM SANTA ANA, Calif.—Johnson & Johnson Vision has completed its previously announced acquisition of TearScience Inc., a medical device manufacturer that focuses on evaluating meibomian gland health and treating Meibomian Gland Dysfunction (MGD), the leading cause of dry eye disease.

Couple in South Carolina Files Lawsuit Against Amazon Over Defective Eclipse Glasses

By Staff
Monday, September 4, 2017 12:24 AM CHARLESTON, S.C.—A South Carolina couple filed a lawsuit against Amazon Inc. last week in federal district court here, claiming that the online retailer sold faulty glasses that were marketed as being safe for viewing the solar eclipse in mid-August.

Prevent Blindness Works With Eagles Charitable Foundation to Train Philadelphia School Nurses

By Staff
Monday, September 4, 2017 12:21 AM PHILADELPHIA—Prevent Blindness, the leading volunteer eye health and safety organization in the U.S., oversaw the administration of vision-screening training and certification at a professional development meeting for Philadelphia school nurses held here Friday.

Zeiss Acquires Veracity Innovations, a Cataract Surgery Platform

By Staff
Wednesday, August 23, 2017 12:30 AM DUBLIN, Calif. and JENA, Germany—Zeiss has acquired Veracity Innovations, a medical software company in Temple, Texas. The purchase price was not disclosed.
Loading...